Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chongcao Qingfei (also known as Chongcao Qingfei Jiaonang or Capsule) is a traditional Chinese medicine (TCM) herbal formulation manufactured by Qinghai Pulante Pharmaceutical. It is an over-the-counter (OTC) product approved by China's State Food and Drug Administration (approval number Z20025121). The formulation contains multiple herbal and animal-derived ingredients, including Chinese Caterpillar Fungus (Cordyceps), Fructus Hippophae, Kadsura Longepedunculata, Stemona Root, Common Bletilla, Lily Bulb, Loquat Leaf, Liquorice Root, Oyster Shell, and Tokay Gecko. This herbal medicine is indicated for treating chronic obstructive pulmonary disease (COPD), chronic bronchitis, asthma, and respiratory symptoms associated with qi and yin deficiency, including cough, excessive phlegm, and chest tightness. As a traditional Chinese medicine formulation, it does not have a single active ingredient or defined biological target in the Western pharmaceutical sense, but rather works through the combined effects of its multiple herbal components.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Chongcao Qingfei.